Epochs in the depressor/pressor balance of the renin–angiotensin system
- 1 April 2016
- journal article
- review article
- Published by Portland Press Ltd. in Clinical Science
- Vol. 130 (10), 761-771
- https://doi.org/10.1042/cs20150939
Abstract
The renin–angiotensin system (RAS) plays a commanding role in the regulation of extracellular fluid homoeostasis. Tigerstadt and Bergman first identified the RAS more than two centuries ago. By the 1980s a voyage of research and discovery into the mechanisms and actions of this system led to the development of drugs that block the RAS, which have become the mainstay for the treatment of cardiovascular and renal disease. In the last 25 years new components of the RAS have come to light, including the angiotensin type 2 receptor (AT2R) and the angiotensin-converting enzyme 2 (ACE2)/angiotensin-(1–7) [Ang(1–7)]/Mas receptor (MasR) axis. These have been shown to counter the classical actions of angiotensin II (AngII) at the predominant angiotensin type 1 receptor (AT1R). Our studies, and those of others, have demonstrated that targeting these depressor RAS pathways may be therapeutically beneficial. It is apparent that the evolution of both the pressor and depressor RAS pathways is distinct throughout life and that the depressor/pressor balance of the RAS vary between the sexes. These temporal patterns of expression suggest that therapies targeting the RAS could be optimized for discrete epochs in life.Keywords
This publication has 104 references indexed in Scilit:
- Differential Mechanisms of Ang (1-7)-Mediated Vasodepressor Effect in Adult and Aged Candesartan-Treated RatsInternational Journal of Hypertension, 2011
- Emerging Role of Relaxin in the Maternal Adaptations to Normal Pregnancy: Implications for PreeclampsiaSeminars in Nephrology, 2011
- Angiotensin (1-7) Receptor Antagonism Equalizes Angiotensin II–Induced Hypertension in Male and Female Spontaneously Hypertensive RatsHypertension, 2010
- Postmenopausal Hypertension: Role of the Renin-Angiotensin SystemHypertension, 2010
- Sex differences in acute ANG II-mediated hemodynamic responses in miceAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2010
- Stimulation of angiotensin AT2 receptors by the non‐peptide agonist, Compound 21, evokes vasodepressor effects in conscious spontaneously hypertensive ratsBritish Journal of Pharmacology, 2010
- Sex, diabetes and the kidneyAmerican Journal of Physiology-Renal Physiology, 2009
- Increased vascular angiotensin type 2 receptor expression and NOS-mediated mechanisms of vascular relaxation in pregnant ratsAmerican Journal of Physiology-Heart and Circulatory Physiology, 2009
- Intrarenal Angiotensin III Infusion Induces Natriuresis and Angiotensin Type 2 Receptor Translocation in Wistar-Kyoto but not in Spontaneously Hypertensive RatsHypertension, 2009
- Estrogen Reduces Aldosterone, Upregulates Adrenal Angiotensin II AT2 Receptors and Normalizes Adrenomedullary Fra-2 in Ovariectomized RatsNeuroendocrinology, 2008